
B4 PharmaTech, founded in 2023, specializes in cell-free protein synthesis, offering user-friendly solutions for custom protein production. Their technology enables the synthesis of complex proteins with defined chemical modifications, opening new possibilities for various applications. Services include protein production, membrane proteins, antibodies, protein labeling and modifications, building blocks for synthetic biology, RNA analysis, cell-free systems, and HTS solutions. They leverage AI and machine learning for enzyme engineering and on-chip automation for cell-free protein synthesis.

B4 PharmaTech, founded in 2023, specializes in cell-free protein synthesis, offering user-friendly solutions for custom protein production. Their technology enables the synthesis of complex proteins with defined chemical modifications, opening new possibilities for various applications. Services include protein production, membrane proteins, antibodies, protein labeling and modifications, building blocks for synthetic biology, RNA analysis, cell-free systems, and HTS solutions. They leverage AI and machine learning for enzyme engineering and on-chip automation for cell-free protein synthesis.